Drugs / SCTV01C
Trials 8 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT05043311 | Dec 2021 → Jun 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT05043285 | Dec 2021 → Jun 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 1/2 | NCT05148091 | Dec 2021 → Aug 2023 | COVID-19 | Sinocelltech Ltd. | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT05239975 | Apr → Jul 2022 | COVID-19 | Sinocelltech Ltd. | Withdrawn | No outcome recorded |
| Phase 2 | NCT05308602 | Apr → Aug 2022 | COVID-19 | Sinocelltech Ltd. | Withdrawn | No outcome recorded |
| Phase 2 | NCT05239806 | Apr → Aug 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT05238454 | Mar → Jul 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT05323461 | May → Oct 2022 | COVID-19 | Sinocelltech Ltd. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCTV01C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05323461 ↗ |
| Modality | Vaccine | “a novel bivalent protein vaccine” PMID 36470077 ↗ Dec 2022 |
| Route | Intramuscular | “intramuscular injection” NCT05043285 ↗ |